Novo Nordisk A/S (NYSE:NVO) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Novo Nordisk A/S (NYSE:NVO) ...

Berger Montague PC is investigating claims under the federal securities laws against Novo Nordisk A/S (NYSE: NVO) ("Novo" or the "Company"), a global pharmaceutical company, headquartered in Denmark, ...

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

Cambridge-based Biogen is looking to the growth of its Alzheimer’s drug Leqembi to offset the decline of its multiple ...

A new study has revealed what could be happening to your muscles after taking Ozempic, though clinical trials are needed to test on humans ...

A UK government and Eli Lilly £85 million program will expand obesity care nationwide, offering digital, community, and ...

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern over the use of unapproved GLP-1 receptor agonists for weight loss, such as ...

July, video editor Meng Meng, 38, has been injecting herself with a weekly weight loss drug, hoping it will finally help her ...

Texas Attorney General Ken Paxton is accusing Eli Lilly and Co. of a kickback scheme to induce medical providers to prescribe ...

And it’s a problem with humankind in general. We do tend to crave quick fixes, often in pharmaceutical form. That’s why Henry Dimbleby, a food campaigner and founder of Leon, called Ozempic “the ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...